NeuroSense Therapeutics Ltd. (NRSN) has 10 tenedores institucionales e internos conocidos registrados. El mayor tenedor es Binder Hagit con 521,806 acciones. Otros tenedores destacados incluyen Ben-Noon Alon y Tracik Ferenc.
En los últimos 12 meses, los internos han realizado 25 transacciones en NRSN acciones — 3 compras (valoradas en RSU Award) y 0 ventas (valoradas en RSU Award). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.
NRSN Participación de Insiders
Principal Titular
Binder Hagit
521,806 acciones
Compras (12 meses)
3
$0.00 valor
Ventas (12 meses)
0
$0.00 valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Binder Hagit |
General Manager |
521,806 |
2026-03-30 |
|
| 2 |
Ben-noon Alon |
10 Percent Owner, Officer: Chief Executive Officer |
360,777 |
2026-03-30 |
|
| 3 |
Tracik Ferenc |
Chief Medical Officer |
189,618 |
2026-03-18 |
|
| 4 |
Eisenberg Or |
Chief Financial Officer |
139,416 |
2026-04-01 |
|
| 5 |
Leuchtenberger Mark |
Director |
75,000 |
2026-03-18 |
|
| 6 |
Mandil-levin Revital |
Director |
52,526 |
2026-03-31 |
|
| 7 |
Claiborne Cary J |
Director |
48,000 |
2026-03-18 |
|
| 8 |
Pellizzari Christine A |
Director |
48,000 |
2026-03-18 |
|
| 9 |
Golan Roy |
Director |
24,000 |
2026-03-18 |
|
| 10 |
Russek-blum Niva |
Chief Technology Officer |
10,000 |
2026-03-30 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2026-03-26 |
Eisenberg Or |
Chief Financial Officer |
Concesión de RSU |
200,000 |
- |
- |
| 2026-03-18 |
Eisenberg Or |
Chief Financial Officer |
Desconocido |
- |
- |
- |
| 2024-08-15 |
Eisenberg Or |
Chief Financial Officer |
Desconocido |
66,666 |
$0.75 |
$50K |
| 2021-07-01 |
Eisenberg Or |
Chief Financial Officer |
Desconocido |
21,000 |
$0.03 |
$693.00 |
| 2026-03-18 |
Mandil-levin Revital |
Director |
Desconocido |
- |
- |
- |
| 2023-03-10 |
Mandil-levin Revital |
Director |
Desconocido |
72,000 |
$1.43 |
$102.96K |
| 2026-03-26 |
Russek-blum Niva |
Chief Technology Officer |
Concesión de RSU |
200,000 |
- |
- |
| 2026-03-18 |
Russek-blum Niva |
Chief Technology Officer |
Desconocido |
- |
- |
- |
| 2022-04-25 |
Russek-blum Niva |
Chief Technology Officer |
Desconocido |
36,000 |
$2.18 |
$78.48K |
| 2026-03-26 |
Binder Hagit |
General Manager |
Concesión de RSU |
200,000 |
- |
- |
| 2026-03-18 |
Ben-noon Alon |
10 Percent Owner, Officer: Chief Executive Officer |
Desconocido |
- |
- |
- |
| 2024-12-05 |
Ben-noon Alon |
10 Percent Owner, Officer: Chief Executive Officer |
Desconocido |
80,000 |
$1.25 |
$100K |
| 2024-08-15 |
Ben-noon Alon |
10 Percent Owner, Officer: Chief Executive Officer |
Desconocido |
26,666 |
$0.75 |
$20K |
| 2026-03-18 |
Tracik Ferenc |
Chief Medical Officer |
Desconocido |
- |
- |
- |
| 2024-08-15 |
Tracik Ferenc |
Chief Medical Officer |
Desconocido |
66,667 |
$0.75 |
$50K |
| 2022-03-13 |
Tracik Ferenc |
Chief Medical Officer |
Desconocido |
108,000 |
$3.51 |
$379.08K |
| 2026-03-18 |
Binder Hagit |
General Manager |
Desconocido |
- |
- |
- |
| 2022-11-17 |
Binder Hagit |
General Manager |
Desconocido |
36,000 |
$1.99 |
$71.64K |
| 2026-03-18 |
Golan Roy |
Director |
Desconocido |
- |
- |
- |
| 2026-03-18 |
Claiborne Cary J |
Director |
Desconocido |
- |
- |
- |
| 2023-03-10 |
Claiborne Cary J |
Director |
Desconocido |
72,000 |
$1.43 |
$102.96K |
| 2026-03-18 |
Leuchtenberger Mark |
Director |
Desconocido |
- |
- |
- |
| 2022-01-01 |
Leuchtenberger Mark |
Director |
Desconocido |
192,000 |
$3.51 |
$673.92K |
| 2026-03-18 |
Pellizzari Christine A |
Director |
Desconocido |
- |
- |
- |
| 2023-03-10 |
Pellizzari Christine A |
Director |
Desconocido |
72,000 |
$1.43 |
$102.96K |